Back to Directory Jonathan Lucas Email JLucas@fhi360.org Phone + 1-919-544-7040 x11458 Institution FHI 360 Request an Update Affiliated Studies P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Prevention Study Status Closed to Follow Up IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Follow Up IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Treatment Study Status Pending IMPAACT 2020: SMaRT Kids DAIDS Number 38505 Research Area Tuberculosis Study Status In Development
P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Prevention Study Status Closed to Follow Up
IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Follow Up
IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Treatment Study Status Pending
